CardiGraphormer: Unveiling the Power of Self-Supervised Learning in Revolutionizing Drug Discovery

• URL: http://arxiv.org/abs/2307.00859v4
• Date: Sat, 13 Jan 2024 12:03:25 GMT
• Title: CardiGraphormer: Unveiling the Power of Self-Supervised Learning in Revolutionizing Drug Discovery
• Authors: Abhijit Gupta
• Abstract summary: CardiGraphormer is a novel combination of Graphormer and Cardinality Preserving Attention. SSL performs to learn potent molecular representations and employs GNNs to extract molecular fingerprints. CardiGraphormer's potential applications in drug discovery and drug interactions are vast.
• Score: 0.32634122554914
• License: http://creativecommons.org/licenses/by-sa/4.0/
• Abstract: In the expansive realm of drug discovery, with approximately 15,000 known drugs and only around 4,200 approved, the combinatorial nature of the chemical space presents a formidable challenge. While Artificial Intelligence (AI) has emerged as a powerful ally, traditional AI frameworks face significant hurdles. This manuscript introduces CardiGraphormer, a groundbreaking approach that synergizes self-supervised learning (SSL), Graph Neural Networks (GNNs), and Cardinality Preserving Attention to revolutionize drug discovery. CardiGraphormer, a novel combination of Graphormer and Cardinality Preserving Attention, leverages SSL to learn potent molecular representations and employs GNNs to extract molecular fingerprints, enhancing predictive performance and interpretability while reducing computation time. It excels in handling complex data like molecular structures and performs tasks associated with nodes, pairs of nodes, subgraphs, or entire graph structures. CardiGraphormer's potential applications in drug discovery and drug interactions are vast, from identifying new drug targets to predicting drug-to-drug interactions and enabling novel drug discovery. This innovative approach provides an AI-enhanced methodology in drug development, utilizing SSL combined with GNNs to overcome existing limitations and pave the way for a richer exploration of the vast combinatorial chemical space in drug discovery.

Related papers

• Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural Network with Biomedical Network [69.16939798838159]
  We propose EmerGNN, a graph neural network (GNN) that can effectively predict interactions for emerging drugs. EmerGNN learns pairwise representations of drugs by extracting the paths between drug pairs, propagating information from one drug to the other, and incorporating the relevant biomedical concepts on the paths. Overall, EmerGNN has higher accuracy than existing approaches in predicting interactions for emerging drugs and can identify the most relevant information on the biomedical network.
  arXiv  Detail & Related papers  (2023-11-15T06:34:00Z)
• SynerGPT: In-Context Learning for Personalized Drug Synergy Prediction and Drug Design [64.69434941796904]
  We propose a novel setting and models for in-context drug synergy learning. We are given a small "personalized dataset" of 10-20 drug synergy relationships in the context of specific cancer cell targets. Our goal is to predict additional drug synergy relationships in that context.
  arXiv  Detail & Related papers  (2023-06-19T17:03:46Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• Tailoring Molecules for Protein Pockets: a Transformer-based Generative Solution for Structured-based Drug Design [133.1268990638971]
  De novo drug design based on the structure of a target protein can provide novel drug candidates. We present a generative solution named TamGent that can directly generate candidate drugs from scratch for a given target.
  arXiv  Detail & Related papers  (2022-08-30T09:32:39Z)
• HiGNN: Hierarchical Informative Graph Neural Networks for Molecular Property Prediction Equipped with Feature-Wise Attention [5.735627221409312]
  We propose a well-designed hierarchical informative graph neural networks framework (termed HiGNN) for predicting molecular property. Experiments demonstrate that HiGNN achieves state-of-the-art predictive performance on many challenging drug discovery-associated benchmark datasets.
  arXiv  Detail & Related papers  (2022-08-30T05:16:15Z)
• LIMO: Latent Inceptionism for Targeted Molecule Generation [14.391216237573369]
  We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique. Comprehensive experiments show that LIMO performs competitively on benchmark tasks. One of our generated drug-like compounds has a predicted $K_D$ of $6 cdot 10-14$ M against the human estrogen receptor.
  arXiv  Detail & Related papers  (2022-06-17T21:05:58Z)
• DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations [0.9854322576538699]
  computational screening has become an important way to prioritize drug combinations. DeepDDS was superior to competitive methods by more than 16% predictive precision.
  arXiv  Detail & Related papers  (2021-07-06T08:25:43Z)
• Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers [36.11665744919561]
  Existing drug discovery process is expensive, inefficient and slow. New opportunities to accelerate drug discovery lie at the interface between machine learning methods and physics-based methods. Here, we present an innovative method that combines both approaches to accelerate drug discovery.
  arXiv  Detail & Related papers  (2021-03-04T05:43:18Z)
• A Review of Biomedical Datasets Relating to Drug Discovery: A Knowledge Graph Perspective [4.746544835197422]
  We aim to help guide machine learning and knowledge graph practitioners who are interested in applying new techniques to the drug discovery field. We detail publicly available primary data sources containing information suitable for use in constructing various drug discovery focused knowledge graphs.
  arXiv  Detail & Related papers  (2021-02-19T17:49:38Z)
• Distance-aware Molecule Graph Attention Network for Drug-Target Binding Affinity Prediction [54.93890176891602]
  We propose a diStance-aware Molecule graph Attention Network (S-MAN) tailored to drug-target binding affinity prediction. As a dedicated solution, we first propose a position encoding mechanism to integrate the topological structure and spatial position information into the constructed pocket-ligand graph. We also propose a novel edge-node hierarchical attentive aggregation structure which has edge-level aggregation and node-level aggregation.
  arXiv  Detail & Related papers  (2020-12-17T17:44:01Z)
• Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning [75.95376096628135]
  We propose a novel forward synthesis framework powered by reinforcement learning (RL) for de novo drug design. In this setup, the agent learns to navigate through the immense synthetically accessible chemical space. We describe how the end-to-end training in this study represents an important paradigm in radically expanding the synthesizable chemical space.
  arXiv  Detail & Related papers  (2020-04-26T21:40:03Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.